Creation of a biobank of patients with Progressive Supranuclear Palsy and Corticobasal Syndrome in Argentina
Objective: To generate a longitudinal cohort study and a research-ready biobank of Argentinian patients with corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). Background: Corticobasal…Local field potential changes by the patient’s conditions; 1-year follow-up of adaptive deep brain stimulation in the real world.
Objective: To evaluate changes of local field potential (LFP) in patients with Parkinson’s disease (PD) by patient conditions and overtime for one year after surgery…Role of nanoparticles of berberine on oxidative stress in nigrostriatal tissue and neurobehavioral characteristics in rotenone induced animal model of Parkinson’s disease
Objective: The current study exemplified the therapeutic potential of solid lipid nanoparticles (SLN) of berberine (BE-SLN) against oxidative stress in nigrostriatal tissue and neurobehavioral characteristics…Association between subjective and objective language measures in DBS candidates
Objective: Determine if expressive language measures from neuropsychological testing correspond to subjective communication struggles in Deep Brain Stimulation (DBS) candidates. Background: A number of studies…Brain first-body first: is the dat-scan useful?
Objective: The purpose of this study is to evaluate possible differences in the DAT-SCAN ratios in patients with and without dysautonomia and RBD at diagnosis.…The cause of death in Parkinson’s disease
Objective: To investigate the causes of death in patients with Parkinson's disease at 6 hospitals in Kagawa Prefecture, Japan. Background: Not much literature exists on…Recruitment of Parkinson’s disease patients with mild-to-moderate anxiety into a randomized controlled trial: Experience of a large Canadian tertiary movement disorders clinic
Objective: To report our experience of recruiting Parkinson’s disease (PD) patients with mild-to-moderate anxiety into a randomized controlled trial. Background: Anxiety is a common non-motor…Empowerment of People with Parkinson`s disease: development, testing and evaluation of a cross-sectoral, intervention-based self-management program
Objective: The overall purpose of this study is to develop, test and evaluate the results of a self-management program targeted PwP with the aim of…Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicentre, parallel, randomised, double blind, phase 2b clinical trial
Objective: We aimed to assess whether clonidine, a specific α2-adrenergic receptor agonist, would improve impulse controls disorders (ICDs). Background: ICDs are frequently encountered in Parkinson’s…Baseline characteristics for patients with multiple system atrophy entering a randomized, controlled study of the anti-α-synuclein monoclonal antibody Lu AF82422
Objective: Report baseline characteristics for patients with multiple system atrophy (MSA) entering a study to assess the safety and efficacy of alpha-synuclein (α-syn) monoclonal antibody…
- « Previous Page
- 1
- …
- 156
- 157
- 158
- 159
- 160
- …
- 186
- Next Page »